Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
View ORCID ProfileCarolina Garrido, View ORCID ProfileJillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, View ORCID ProfileTulika Singh, View ORCID ProfileEleanor C. Semmes, Debra J. Lugo, View ORCID ProfileAlexandre T. Rotta, View ORCID ProfileNicholas A. Turner, View ORCID ProfileThomas W. Burke, View ORCID ProfileMicah T. McClain, View ORCID ProfileElizabeth A. Petzold, View ORCID ProfileSallie R. Permar, M. Anthony Moody, Christopher W. Woods, View ORCID ProfileMatthew. S. Kelly, View ORCID ProfileGenevieve G. Fouda
doi: https://doi.org/10.1101/2021.04.17.21255663
Carolina Garrido
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
PhDJillian H. Hurst
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
3Children’s Health & Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, NC
PhDCynthia G. Lorang
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
MSJhoanna N. Aquino
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
BSJavier Rodriguez
4Children’s Clinical Research Unit, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA
Trevor S. Pfeiffer
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
Tulika Singh
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
Eleanor C. Semmes
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
3Children’s Health & Discovery Institute, Department of Pediatrics, Duke University School of Medicine, Durham, NC
5Medical Scientist Training Program, Department of Molecular Genetics and Microbiology, Duke University, Durham, NC
BSDebra J. Lugo
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
MDAlexandre T. Rotta
6Department of Pediatrics, Division of Pediatric Critical Care Medicine, Duke University School of Medicine, Durham, NC
MDNicholas A. Turner
7Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
MD, MHScThomas W. Burke
9Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC
PhDMicah T. McClain
7Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
8Durham Veterans Affairs Medical Center, Durham, NC
9Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC
MDElizabeth A. Petzold
4Children’s Clinical Research Unit, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA
PhDSallie R. Permar
8Durham Veterans Affairs Medical Center, Durham, NC
MD, PhDM. Anthony Moody
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
MDChristopher W. Woods
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
7Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
8Durham Veterans Affairs Medical Center, Durham, NC
9Center for Applied Genomics and Precision Medicine, Duke University, Durham, NC
MD, MPHMatthew. S. Kelly
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
MD, MPHGenevieve G. Fouda
1Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
2Department of Pediatrics, Division of Infectious Diseases, Duke University School of Medicine, Durham, NC
MD, PhDArticle usage
Posted April 20, 2021.
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, Tulika Singh, Eleanor C. Semmes, Debra J. Lugo, Alexandre T. Rotta, Nicholas A. Turner, Thomas W. Burke, Micah T. McClain, Elizabeth A. Petzold, Sallie R. Permar, M. Anthony Moody, Christopher W. Woods, Matthew. S. Kelly, Genevieve G. Fouda
medRxiv 2021.04.17.21255663; doi: https://doi.org/10.1101/2021.04.17.21255663
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido, Jillian H. Hurst, Cynthia G. Lorang, Jhoanna N. Aquino, Javier Rodriguez, Trevor S. Pfeiffer, Tulika Singh, Eleanor C. Semmes, Debra J. Lugo, Alexandre T. Rotta, Nicholas A. Turner, Thomas W. Burke, Micah T. McClain, Elizabeth A. Petzold, Sallie R. Permar, M. Anthony Moody, Christopher W. Woods, Matthew. S. Kelly, Genevieve G. Fouda
medRxiv 2021.04.17.21255663; doi: https://doi.org/10.1101/2021.04.17.21255663
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2949)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12754)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4588)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2921)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4366)
- Nursing (236)
- Nutrition (640)
- Oncology (2273)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6947)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)